CARIS LIFE SCIENCES, INC. (CAI) Debt / Equity
- 2026-06-30: Debt/Equity Ratio 0.66.
- 2026-03-31: Debt/Equity Ratio 0.64.
- 2025-12-31: Debt/Equity Ratio 0.66.
- 2025-09-30: Debt/Equity Ratio 0.79.
Complete source-backed debt/equity ratio history.
- Available history
- 2024-12-31 to 2026-06-30
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2026-06-30 | 0.66 |
| 2026-03-31 | 0.64 |
| 2025-12-31 | 0.66 |
| 2025-09-30 | 0.79 |
| 2025-06-30 | 0.83 |
| 2024-12-31 | -0.15 |
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2025-12-31 | 0.66 |
| 2024-12-31 | -0.15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |